Baird Maintains Outperform on Boston Scientific, Raises Price Target to $51
Benzinga Newsdesk 3 days ago
Analyst RatingsNewsPrice TargetHot
Baird analyst David Rescott maintains Boston Scientific (NYSE:BSX) with a Outperform and raises the price target from $50 to $51.
Baird analyst David Rescott maintains Boston Scientific (NYSE:BSX) with a Outperform and raises the price target from $50 to $51.